Luc Valiquette

Summary

Affiliation: University of Montreal
Country: Canada

Publications

  1. ncbi request reprint Vardenafil provides reliable efficacy over time in men with erectile dysfunction
    Francesco Montorsi
    Instituto San Raffaele, Milan, Italy
    Urology 64:1187-95. 2004
  2. ncbi request reprint Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis
    Luc Valiquette
    Service d Urologie, CHUM Hopital St Luc, Montreal, Quebec, Canada
    Can J Urol 12:2687-98; discussion 2699. 2005
  3. ncbi request reprint Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled study
    Luc Valiquette
    Service d Urologie, Hôpital St Luc du CHUM, 1058 rue Saint Denis, Montreal, Quebec, Canada
    Mayo Clin Proc 80:1291-7. 2005
  4. ncbi request reprint First-dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY-I
    L Valiquette
    Department of Urology, Hôpital St Luc du CHUM, Montreal, Quebec, Canada
    Int J Clin Pract 60:1378-85. 2006
  5. doi request reprint Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer
    Umberto Capitanio
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    Urology 73:1087-91. 2009
  6. ncbi request reprint Baseline prevalence of erectile dysfunction in a prostate cancer screening population
    Jochen Walz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    J Sex Med 5:428-35. 2008
  7. doi request reprint Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapy
    Giovanni Lughezzani
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 78:1307-13. 2010
  8. doi request reprint The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients
    Naeem Bhojani
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
    Int J Radiat Oncol Biol Phys 76:342-8. 2010
  9. doi request reprint Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population
    Jochen Walz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    J Endourol 22:369-76. 2008
  10. doi request reprint A population based assessment of perioperative mortality after cystectomy for bladder cancer
    Hendrik Isbarn
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    J Urol 182:70-7. 2009

Collaborators

Detail Information

Publications30

  1. ncbi request reprint Vardenafil provides reliable efficacy over time in men with erectile dysfunction
    Francesco Montorsi
    Instituto San Raffaele, Milan, Italy
    Urology 64:1187-95. 2004
    ..To evaluate the reliability of vardenafil efficacy and tolerability within 12 weeks in a broad population of men with erectile dysfunction (ED)...
  2. ncbi request reprint Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis
    Luc Valiquette
    Service d Urologie, CHUM Hopital St Luc, Montreal, Quebec, Canada
    Can J Urol 12:2687-98; discussion 2699. 2005
    ....
  3. ncbi request reprint Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled study
    Luc Valiquette
    Service d Urologie, Hôpital St Luc du CHUM, 1058 rue Saint Denis, Montreal, Quebec, Canada
    Mayo Clin Proc 80:1291-7. 2005
    ..To evaluate the reliability, efficacy, and safety of vardenafil, 10 mg, for patients with erectile dysfunction...
  4. ncbi request reprint First-dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY-I
    L Valiquette
    Department of Urology, Hôpital St Luc du CHUM, Montreal, Quebec, Canada
    Int J Clin Pract 60:1378-85. 2006
    ..Vardenafil 10 mg is generally well tolerated and efficacious, providing first-dose success with a consistently high rate of reliability of penetration and maintenance of erection in men with ED and associated comorbidities...
  5. doi request reprint Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer
    Umberto Capitanio
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    Urology 73:1087-91. 2009
    ..To examine the effect the number of biopsy cores taken has on the rate of clinically significant Gleason sum upgrading (GSU) in patients with low-risk prostate cancer...
  6. ncbi request reprint Baseline prevalence of erectile dysfunction in a prostate cancer screening population
    Jochen Walz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    J Sex Med 5:428-35. 2008
    ....
  7. doi request reprint Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapy
    Giovanni Lughezzani
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 78:1307-13. 2010
    ....
  8. doi request reprint The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients
    Naeem Bhojani
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
    Int J Radiat Oncol Biol Phys 76:342-8. 2010
    ..We tested this hypothesis in a large French Canadian population-based cohort of prostate cancer patients...
  9. doi request reprint Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population
    Jochen Walz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    J Endourol 22:369-76. 2008
    ..Therefore, we assessed baseline rates of LUTS in a PCa screening cohort and assessed which of the International Prostate Symptom Score (IPSS) symptoms had the most detrimental effect on quality of life (QoL)...
  10. doi request reprint A population based assessment of perioperative mortality after cystectomy for bladder cancer
    Hendrik Isbarn
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    J Urol 182:70-7. 2009
    ..Contemporary estimates range from 0.7% to 5.6%. We tested several predictors of perioperative mortality and devised a model for individual perioperative mortality prediction...
  11. ncbi request reprint A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer
    Jochen Walz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    J Clin Oncol 25:3576-81. 2007
    ..To circumvent this problem, we developed a nomogram predicting 10-year LE for patients treated with either radical prostatectomy (RP) or external-beam radiation therapy (EBRT) and compared it with an existing tool...
  12. doi request reprint Responsiveness and clinical utility of the geriatric self-efficacy index for urinary incontinence
    Cara Tannenbaum
    Center for Research, Institut Universitaire de Geriatrie de Montreal, Quebec, Canada
    J Am Geriatr Soc 57:470-5. 2009
    ..To report on the responsiveness testing and clinical utility of the 12-item Geriatric Self-Efficacy Index for Urinary Incontinence (GSE-UI)...
  13. doi request reprint Accuracy of life tables in predicting overall survival in patients after radical prostatectomy
    Jochen Walz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    BJU Int 102:33-8. 2008
    ....
  14. ncbi request reprint Ejaculatory disorders may affect screening for prostate cancer
    Jochen Walz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    J Urol 178:232-7; discussion 237-8. 2007
    ..Therefore, we explored the prevalence of those disorders and associated bother in men without evidence of prostate cancer who participated in an annual prostate cancer screening event...
  15. ncbi request reprint High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer
    Claudio Jeldres
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
    Eur Urol 54:97-105. 2008
    ..We examined the effect of annual and cumulative provider volume on the rate of use of secondary therapies after definitive external-beam radiotherapy (EBRT) for localized prostate cancer...
  16. ncbi request reprint Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer
    Jochen Walz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    BJU Int 100:1254-8. 2007
    ....
  17. doi request reprint Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection
    Maxine Sun
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    J Urol 183:970-5. 2010
    ....
  18. doi request reprint Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy
    Hendrik Isbarn
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    J Endourol 23:1347-52. 2009
    ..Our objective was to examine the rate and the predictors of 30-day mortality (30dM) after TURP in patients who were exposed to ADT in a large, contemporary Canadian cohort...
  19. ncbi request reprint Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer
    Jochen Walz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 69:88-94. 2007
    ..To test the accuracy of life tables (LTs) in predicting survival in men treated with radiotherapy for localized prostate cancer...
  20. ncbi request reprint Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer
    Andrea Gallina
    Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    BJU Int 99:1404-8. 2007
    ....
  21. ncbi request reprint Screening men for prostate cancer and colorectal cancer: is practice evidence-based?
    Felix K H Chun
    Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    Can J Urol 14:3727-33. 2007
    ..We aimed to examine the rate of exposure to previous screening tests for prostate cancer and colorectal cancer in a cohort of men living in Quebec...
  22. ncbi request reprint Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men
    Jochen Walz
    Cancer Prognostics and Health Outcomes Unit, and Department of Urology, University of Montreal, Montreal, Quebec, Canada
    BJU Int 100:1307-11. 2007
    ....
  23. doi request reprint Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia
    Claudio Jeldres
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada
    J Urol 182:626-32. 2009
    ....
  24. doi request reprint Training and outcome monitoring in robotic urologic surgery
    Daniel Liberman
    Department of Urology, University of Montreal Health Center CHUM, Suite 301, 235 Boulevard Rene Levesque Est, Montreal, QC H2X 1N8, Canada
    Nat Rev Urol 9:17-22. 2012
    ..Guidelines for outcome monitoring following RS should be developed, to ensure patient safety and sufficient baseline surgeon skill...
  25. doi request reprint Creation and testing of the Geriatric Self-Efficacy Index for Urinary Incontinence
    Cara Tannenbaum
    Centre de Reserche, Institut Universitaire de Geriatrie de Montreal, Montreal, Quebec, Canada
    J Am Geriatr Soc 56:542-7. 2008
    ..To report on the content development, construct validity, and reliability testing of the Geriatric Self-Efficacy Index for Urinary Incontinence (GSE-UI)...
  26. ncbi request reprint Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening
    Georg Hutterer
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 1058, rue St Denis, Montreal, Que, Canada
    Eur J Cancer 43:1180-7. 2007
    ..Body mass index (BMI) may alter serum prostate specific antigen (PSA) and percent free PSA (%fPSA) and may mask the risk of prostate cancer. We investigated the relationship between BMI and PSA or %fPSA...
  27. pmc Vardenafil demonstrates first-dose success and reliability of penetration and maintenance of erection in men with erectile dysfunction - RELY-II
    Luc Valiquette
    Hôpital St Luc du CHUM, Montreal, Que
    Can Urol Assoc J 2:187-95. 2008
    ..Vardenafil has been shown to be efficacious in patients with erectile dysfunction (ED). We evaluated first-dose and repeat-dose response to vardenafil 20 mg...
  28. ncbi request reprint Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy
    Andrea Gallina
    Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    Eur Urol 52:98-105. 2007
    ..We hypothesized that contemporary patients, at very low risk of seminal vesicle invasion (SVI), can be highly accurately identified with an equally contemporary SVI nomogram...
  29. ncbi request reprint A historical review of erectile dysfunction
    Luc Valiquette
    Department of Surgery Urology, University of Montreal, 301 235 blvd René Lévesque Est, Montreal, Quebec H2X 1N8, Canada
    Can J Urol 10:7-11. 2003
    ..This article will evaluate the therapeutic options, from a historical perspective of what has been available, and outline the progress that has been made...
  30. ncbi request reprint Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate
    Gregory A Broderick
    Department of Urology, Mayo Clinic, Jacksonville, FL 32224, USA
    J Sex Med 3:668-75. 2006
    ..Tadalafil, an inhibitor of phosphodiesterase 5 (PDE5), is indicated for treatment of erectile dysfunction. Most tadalafil clinical trials excluded patients with unsuccessful prior treatment with sildenafil citrate (sildenafil)...